Novartis Animal Health has launched 'The Wormer Decision Tree', an online tool to help veterinary surgeons in giving sheep farmers the most up-to-date advice about worming.
Lesley Stubbings, SCOPS representative and Independent Sheep Consultant said: “Choosing the right wormer group is hugely important and there remains much confusion especially when it comes to anthelmintic resistance.
“Worms, including resistant and multi-resistant species, are threatening the productivity of sheep farms. However with a well-thought-out worming strategy that uses both the new wormer groups, in association with existing wormers, it is possible to slow resistance.”
Results of the Farming Against Wormer Resistance (FAWR) campaign survey, conducted in 2013, revealed growing concern about wormer resistance among farmers - but confusion about the best course of action to take.
Fiona Anderson, Novartis Animal Health Veterinary Manager said: "This tool has been developed adhering to SCOPS principles and is designed to ensure a consistent responsible approach is used when prescribing anthelmintics.
"Available only to SQPs and vets, it will be a valuable tool to train new staff and use with farmers, to explain which of the five drench classes are appropriate for particular sheep groups at specific times of year."
The Novartis Wormer Decision Tree asks three key questions: the type of sheep being dosed, the purpose of the dose, and the farm's resistance status. It then produces a recommendation of the required active ingredient, along with more detailed information to support the recommendation. There is also a calculator which provides a dose rate and cost per dose based upon the recommendation.
To use the decision tree, you must first register on the Novartis Farm Animal Health website: www.farmanimalhealth.co.uk. Then head here: www.farmanimalhealth.co.uk/wormerdecisiontree
Dechra Veterinary Products has launched Anesketin, an anaesthetic licensed for cats, dogs and horses.
Anesketin contains ketamine 100mg/ml solution for injection and is indicated for induction of anaesthesia. In cats, it can also be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required.
Dechra Brand Manager Carol Morgan said: "Anesketin is a versatile product which can be used as a sole agent in cats or in combination with appropriate sedatives and analgesics in cats, dogs and horses for induction and maintenance of anaesthesia.
Anesketin is available in 10 ml vials. The withdrawal period for meat, offal and milk is one day and the product does not require any special storage conditions.
For further information, visit www.dechra.co.uk
Royal Canin has announced the launch of two new veterinary diets designed to tackle obesity in cats and dogs.
'Satiety Small Dog' is for adult dogs with an ideal weight up to 10kg. 'Satiety Wet' has been developed for those dogs who prefer wet food, or who are used to eating a combination of wet and dry food.
Satiety Small Dog is available in 1.5kg, 3.5kg and 8kg bags and contains a blend of fibres that Royal Canin says increases the volume of stomach contents and promotes satiety. The company says the new diet also contains specific nutrients which contribute to maintaining good oral health, and a high protein content to help maintain muscle mass during the weight loss programme.
Satiety Small Dog is designed to improve digestive tolerance in smaller breeds, as it has a different blend of fibre and higher levels of butyrate than Satiety Canine, which is formulated for the needs of medium and larger dogs. The diet contains less dietary oxalate which Royal Canin claims is of benefit to smaller dogs that are at a greater risk of developing calcium oxalate uroliths.
The second new diet, Satiety Wet for Dogs, is available in 410g and 195g cans. The diet has a high protein content (14.1g per 100kcal), and is enriched with nutrients, minerals and vitamins. Royal Canin also highlights what it says is a particularly innovative feature: a high fibre content in a canned diet.
Ian Williams, Veterinary Scientific Support Manager at Royal Canin, said: "Almost 60% of dogs and 40% of cats in the UK and Ireland are overweight or obese. With obesity comes an increased risk of animals developing conditions affecting the upper respiratory tract, cardiopulmonary system, joints and urinary tract. In cats obesity is also a major risk factor for Type II diabetes mellitus. In essence, obesity can lead to a decreased life expectancy and a reduced quality of life.
"Royal Canin has a proven track record of developing innovative diets to help these pets and the latest additions to our range really will complement the existing choice for vets and their clients."
A new US colic study, published in Equine Veterinary Journal (EVJ), in partnership with the American Association of Equine Practitioners, has identified various risk factors, including delayed faecal output and increasing blood lactate, associated with post-anaesthetic colic.
The study Risk factors associated with gastrointestinal dysfunction in horses undergoing elective procedures under general anaesthesia was conducted by surgeons based at the College of Veterinary Medicine and Biomedical Sciences at Colorado State University, USA.
The authors say that the research should enable vets to implement preventative measures to help reduce incidences of colic in the future.
Gastrointestinal pain has been estimated to occur in 2.8-6% of horses following general anaesthesia for elective procedures, the most common cause being impaction of the large intestine or caecum.
The medical records of 416 horses undergoing general anaesthesia were collected over a two-year period and the potential risk factors were examined. 8.7% of horses were diagnosed with gastrointestinal dysfunction - higher than previous estimates probably because the study included horses requiring treatment for decreased faecal output whereas previous studies did not. Potential risk factors were assessed, including faecal output, which was decreased in 38.9% of cases, blood lactate, position during surgery, rectal temperature and breed of horse.
The results showed that Arabian horses, increasing blood lactate, right lateral recumbency, decreased rectal temperature post-procedure and delayed passage of faeces were significantly associated with an increased risk of gastrointestinal dysfunction.
Diana Hassel, who instigated the study, said: "These findings should help the clinician identify higher risk horses and be proactive about their management in the post-anaesthetic period.
"This may include pre-emptive nasogastric intubation and administration of mineral oil and/or water and electrolytes. Although core temperature control in horses is difficult to achieve in adult horses during surgery, further research into this field may prove beneficial."
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "This study brings obvious and immediate practical benefits for clinicians and the horses under their care. Rigorous monitoring of higher risk surgical cases should lead to a reduction in incidences of post-operative colic, making recovery procedures less difficult and outcomes more favourable."
A study published in Current Biology has demonstrated that there are remarkable similarities in the way that dog and human brains respond to sound, and that dog brains, like those of people, are also sensitive to acoustic emotional cues.
Lead by Attila Andics, researchers from MTA-ELTE Comparative Ethology Research Group in Hungary trained 11 dogs to lay motionless in an fMRI brain scanner. This made it possible to run the same neuroimaging experiment on both dog and human participants - something that had never been done before. They captured both dogs' and humans' brain activities while the subjects listened to nearly 200 dog and human sounds, ranging from whining or crying to playful barking or laughing.
The resultant scans showed that dog and human brains include voice areas in similar locations. Not surprisingly, the voice area of dogs responds more strongly to other dogs while that of humans responds more strongly to other humans.
The researchers also noted striking similarities in the ways the dog and human brains process emotionally loaded sounds. In both species, an area near the primary auditory cortex lit up more with happy sounds than unhappy ones. Andics says the researchers were most struck by the common response to emotion across species.
There were some differences, too: in dogs, 48% of all sound-sensitive brain regions respond more strongly to sounds other than voices. That's in contrast to humans, in which only 3% of sound-sensitive brain regions show greater response to nonvocal versus vocal sounds.
The researchers say that the findings suggest that voice areas evolved at least 100 million years ago, the age of the last common ancestor of humans and dogs. It also offers new insight into humans' unique connection with our best friends in the animal kingdom and helps to explain the behavioural and neural mechanisms that made this alliance so effective for tens of thousands of years.
Andics said: "This method offers a totally new way of investigating neural processing in dogs. At last we begin to understand how our best friend is looking at us and navigating in our social environment."
Photograph: Borbala Ferenczy. Dogs at the MR Research Centre (Budapest).
Organisers of The Vet Charity Challenge, which last year raised £50,000 for charity, have announced that the event will take place Saturday 27th September 2014 in Pewsey, near Marlborough, Wiltshire.
The event consists of teams of four walking/running, cycling and kayaking as well as some orienteering and mental and physical tasks.
Registration will open at the start of April. Organisers say that spaces are limited and in 2013 filled up very fast, so early booking is advisable.
The charities being supported in 2014 will be Hearing Dogs for Deaf People, SPANA and Cats Protection.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse and Vetoquinol and supported by the VMPA and Veterinary Practice magazine.
For more information visit www.vetcharitychallenge.co.uk.
Canterbury-based solicitor Cooper & Co, which specialises in dog law, has launched a series of CPD-qualifying webinars for veterinary professionals available at www.doglaw.tv.
The webinars, which are presented by Trevor Cooper, cover a wide variety of subjects, including:
In addition, the site hosts videos about dog behaviour by the well-known dog trainer and behaviourist Carolyn Menteith. The topics covered in her videos include:
Whilst the videos are CPD-qualifying for veterinary professionals, they are also aimed at anyone else that works with dogs, and dog owners themselves.
To view the videos visit www.doglaw.tv.
Novartis Animal Health has launched Farming against BVD, a new initiative to help in the fight against Bovine Viral Diarrhoea (BVD).
The campaign, which is being carried out in partnership with key industry bodies, will begin with an independent survey of farmers, the results of which will be announced in April.
An expert panel, headed by Professor Joe Brownlie (Royal Veterinary College and Chairman of the BVD Scientific and technical working group), will then come together to analyse the findings, using them to shape and drive an industry response.
Professor Brownlie said: "BVD is a costly and complex disease, spread by a pestivirus that affects the reproductive and immune systems. Persistently Infected (PI) animals are the main source of infection, but can be hard to identify without testing. Only total eradication will prevent the disease from spreading. Eradication Schemes in a number of European countries have already succeeded and Scotland and Ireland have embarked on similar schemes. The information being gathered will help the industry to develop a much needed scheme for England and Wales."
Joining Professor Joe Brownlie on the expert panel will be Dr Peter Nettleton (Moredun Research Institute), Mansel Raymond (dairy farmer and Chairman of the NFU Dairy Board), Caroline Dawson (Novartis Animal Health veterinary surgeon) and Paddy Gordon (veterinary practitioner).
Survey topics will include levels, and methods, of testing for BVD on farm, understanding of the role of PI animals and the financial impact of BVD on dairy and beef units. Farmers will also be asked who they look to for advice and how they view the role of vaccination.
Caroline Dawson MRCVS from Novartis Animal Health said: "Countrywide eradication may not be achieved for a number of years, although individual farmers can control the disease on their own farms within 1-2 years, providing substantial cost benefits. The purpose of this campaign is to encourage farmers to take action now against BVD. By working closely with their vets, identifying and removing PI animals, BVD can be removed. Ensuring adequate biosecurity and a robust vaccination policy will eliminate the risk of bringing BVD back onto the farm."
Professor Brownlie said: "Understanding what farmers understand about BVD, particularly the role of the PI animal, will enable members of the panel and the wider industry, including Novartis and the BVD Stakeholder Group, to meet farmer needs more accurately. Greater awareness of the problem is vital - this is the only way that progress towards eradication will be made."
Horses suffering from neurological conditions similar to those that affect humans could be helped by a breakthrough from stem cell scientists, according to a study published in the journal Stem Cells and Development.
Researchers at the University of Edinburgh's Roslin Institute took skin cells from a young horse and turned them into stem cells using a technique that was originally developed for human cells. The reprogrammed cells are pluripotent, which means they can be induced to become any type of cell in the body. The team used them to create nerve cells in the laboratory and tested whether they were functional by showing that they could transmit nerve signals in a test tube.
The university says horse stem cells have been produced in the laboratory before but this is the first time that scientists have created working cells of a specific type from them. The advance may pave the way for cell therapies that target conditions similar to motor neurone disease.
In addition, the research could also benefit horses affected by grass sickness, a neurological condition that affects around 600 horses a year in the UK. Little is known about the disease, which causes nerve damage throughout the body. It is untreatable and animals with the most severe form usually die or have to be put down.
Dr Xavier Donadeu from the Roslin Institute, an author of the study, said: "Stem cells hold huge therapeutic potential both for people and animals. Our research is an important step towards realising that potential for horses and provides an opportunity to validate stem-cell based therapies before clinical studies in humans."
The British Association of Veterinary Emergency and Critical Care (BAVECC) is carrying out a survey of the veterinary profession about 24/7 emergency veterinary cover, the results of which will be presented to the RCVS Standards Committee during its forthcoming review.
Toby Birch MRCVS from BAVECC said: "We are aware that there has been much debate on the subject however we feel that much of what has been aired is subjective opinion. While we appreciate that this is very valuable, BAVECC would like to try and place some objectivity on this matter."
If you're working in small animal practice in the UK, please take part in the survey here: https://www.surveymonkey.com/s/JYKNC5J.
The results will be shared with members of VetSurgeon.org and VetNurse.co.uk in due course.
The RCVS has announced that 19 people are standing in this year's RCVS Council elections, including, for the first time, more women than men, and a much lower average candidate age.
Of the 19 candidates - believed to be the highest number since records began - ten are women. Not only is this the most women ever to stand, but it is in direct contrast to last year where all 13 candidates were men. Additionally, whereas the average age of all elected Council members in March 2013 was 56.5 (57 for women and 56 for men), the average age of this year's candidates is 47 (45 for women and 48 for men).
The RCVS Council candidates are:
Last year, the all-male candidate list prompted concern from the profession and calls for the College to investigate the reasons behind the lack of women and to take steps to redress the balance. The then RCVS President Jacqui Molyneux invited feedback from the profession about the barriers to joining Council, and set up a working party, chaired by Council member Amanda Boag, to look at how participation could be widened, not only to women, but also younger members of the profession and those actively engaged in clinical practice.
The working party suggested a number of initiatives, including a mentoring scheme, providing more practical information about being a Council member (see www.youtube.com/rcvsvideos), and inviting prospective candidates to the RCVS to discuss the role in more detail.
Amanda said: "The College's efforts to broaden participation in its election process seem to have paid dividends. I'm delighted there is so much more diversity amongst the election candidates this year, and that so many women have decided to throw their hat into the ring, especially as women now form over 50% of the profession. I'm very much looking forward to the outcome of the elections, and hope that this dramatic increase in candidates in turn prompts an excellent turnout."
In a slightly later start to the voting period this year, ballot papers and candidate details will be posted on 19 March 2014, and all votes must be cast, either online or by post, by 5pm on Friday, 25 April 2014.
In the meantime, the College is inviting all voters to think about the one question they would like to put to the candidates and submit it in time for this year's 'Quiz the Candidates', to be broadcast by the Webinar Vet on the evening of 20 March. All questions received will be put to the candidates, who will each then answer two questions of their choice, as well as explaining what they consider sets them apart as a potential Council member. The candidates' answers will be pre-recorded (due to the large number of candidates) and made available online at around 8:00pm on 20th March.
Questions (one per person) for RCVS Council should be submitted to the RCVS by 12 March via its dedicated election websites, available soon at www.votebyinternet.com/vetvote14, on twitter using the hashtag #vetvote14, or by email to vetvote14@rcvs.org.uk.
Bayer Animal Health has launched a new initiative designed primarily to help veterinary students and bridge gaps in their knowledge about the use of veterinary antibiotics.
The initiative kicks off with two surveys, one for qualified veterinary surgeons here, and one for veterinary students here. The objective of the surveys is to gain an insight into the use and understanding of antibiotics both in practice and in training. They also aim to discover the influences and concerns involved when veterinary surgeons select a course of antibiotics.
The results of the survey will be shared with the profession and used to develop a new educational resource which will be shaped by the results of the survey and available to students in their clinical years. Bayer says it hopes the new resource may also be beneficial for vets in practice who have concerns about the use of antibiotics.
If that isn't reason enough to take part in the survey, all participants will be entered into a draw for an iPad mini.
Vicky McAlister, Group Product Manager at Bayer said: "The importance of understanding the concerns of vets and vet students in responsibly prescribing antibiotics is essential when looking at the issue of antibiotic resistance and the implications for the future of animal health. The large number of antibiotics available can present a challenge and lead to confusion when prescribing. The surveys provide a unique opportunity for vets and students to shape learning and reference resources that address the specific challenges they face when choosing and using antibiotics".
The surveys close on 24th March 2014.
The RCVS is reminding veterinary surgeons that their renewal fees to remain on the Register for 2014/15 are now due.
Registration renewal forms have been sent to all vets reminding them that payment to remain on the Register is due by 31 March 2014. If the College does not receive payment before 1 April, £35 will be added to the renewal fee and any vets who have still not paid before 1 June will be removed from the Register.
This year the RCVS has updated its online 'My Account' area (www.rcvs.org.uk/login) to allow vets to manage their details and pay their renewal fees more quickly and easily. Login details have been sent to all vets and the system is now operational. The changes to the area are the first phase of a project to make it more accessible and user-friendly and to allow vets to better manage their details online.
As part of the renewal process, vets are asked to confirm that their details on the Register are correct, including membership category and correspondence details. Those who are in the 'UK Practising' or 'Practising outside the UK' membership categories should also confirm - via the registration renewal form or the online 'My Account' area - that they are compliant with the requirements for continuing professional development (CPD) of 105 hours over three years. Vets with any cautions, convictions or adverse findings against them dating from 1 January 2006 onwards, should also declare them. For further details on these declarations vets should visit www.rcvs.org.uk/convictions.
Fees can be paid by credit card through the 'My Account' area or by cheque, bank draft or credit card via the registration renewal form sent in the post. Details of how to pay by bank transfer are also on the form.
Vets who have any concerns or questions about renewing their registration, logging in to 'My Account' or who need to request a registration renewal form, can contact the Registration Department on 020 7202 0707 or email membership@rcvs.org.uk.
The Bella Moss Foundation and the Royal Society of Medicine have announced 'One Health', a conference which will bring together experts from the veterinary and medical sectors to collaborate on infectious disease.
Subjects under discussion will include infection control, antimicrobial resistance and the threats posed by emerging zoonotic diseases. Amongst the speakers will be Professor Peter Borriello, Chief Executive of the Veterinary Medicines Directorate and Professor Anthony Kessel, Director of Public Health England. The audience will include policy makers and clinicians together with researchers and academics from both human and veterinary medicine.
Jill Moss, President of the Bella Moss Foundation, said: "With antimicrobial resistance and updated protocols hitting the headlines regularly, our speakers will discuss the key issues. For instance, what exactly is the current status of antimicrobial resistance? How is it affecting our lives? What are the veterinary, medical and research professions doing to resolve the challenges we face - and how can they persuade policy makers to take a united stand on the issue?"
Tom Keith - Welsh president of comparative medicine network, Royal Society of Medicine, said: "Antimicrobial resistance is a global issue requiring education, information and action. The conference programme will provide anyone with an interest in antimicrobial resistance a current and rounded perspective on this important and pressing issue."
For more information, visit: www.onehealthbmf.com.
Dechra Veterinary Products has launched Buprenodale, an opioid analgesic for cats, dogs and horses presented in a 10ml multi-dose vial.
Carol Morgan, Brand Manager said: "Following on from the introduction of Comfortan and Anesketin, our Buprenodale Multidose, 0.3 mg/ml solution for injection for dogs, cats and horses, is the latest addition to the portfolio.
"The active substance in Buprenodale is buprenorphine, the most commonly used opioid analgesic in small animal practice in the UK.
"Buprenodale Multidose joins a portfolio of Dechra products covering a wide range of species, different levels of analgesic efficacy and duration of action.
"The product is now available in a 10 ml multidose vial. It is suitable for post-operative analgesia in dogs and cats; post operative analgesia, in combination with sedation, in horses and potentiation of the sedative effects of centrally acting agents in the dog and horse."
For more information www.dechra.co.uk .
Kruuse UK has announced the launch of its new Mud Fever Kits for horses.
Kruuse says the launch follows independent studies last year by Aimi Duff BVM&S, MRCVS (Scott, Mitchell & Associates, Hexham) on the use of Manuka ND dressings for the treatment of Mud Fever.
The kit contains one complete treatment for two legs (or two complete treatments for one leg) including all dressings. There is also a step-by-step guide from the "Ask the Vet" series which explains best treatment protocol, designed to help veterinary surgeons dispense the kit directly to clients with confidence.
According to the company, the benefits of using medical grade Manuka Honey in the treatment of Mud Fever include:
Andrew Groom, Managing Director of Kruuse UK Ltd said: "We are delighted with the initial response to our unique Mud Fever Kits; such additions to our range continue to enhance the Kruuse commitment to equine wound care."
The Pet Food Manufacturers Association (PFMA) has published the results of research which found that veterinary surgeons believe 45% of all pets are overweight.
In addition, 77% of the 180 vets surveyed at the London Vet Show 2013 believe that the pet obesity problem is on the rise.
Meanwhile, 93% of pet owners said they would be concerned to discover their pet is overweight, revealing a sharp divide between vets' and owners' perceptions.
To help spread the word about ideal pet weight, the PFMA will launch a new campaign called #GetPetsFit on 7th May.
Michael Bellingham, Chief Executive of PFMA said: "We need to engage pet owners emotionally, helping them realise that feeding and exercising their pet to the optimum level can result in an extra two years of active life. The #GetPetsFit campaign will provide the perfect opportunity to do this and we hope that with the help of vets, we can work to resolve this important issue."
The PFMA is urging practices to promote good nutrition and a healthy lifestyle. Zara Boland BVSc BE MRCVS, Founder of Vet Voice Ltd says: "It is encouraging that success rates are high for the 78% of UK vets already running companion animal obesity clinics. However, we must continue pushing the health message until overweight pets are no longer seen as the 'norm'. We need widespread recognition of pet obesity to pave the way for positive action."
One way that the PFMA is encouraging practices to get involved is by running Weigh in Wednesdays from 7th May. To help, the organisation has prepared a free kit that contains campaign posters, website banners and client hand-out materials, including Pet Size-O-Meters (for cats, dogs, rabbits and birds), a pet food diary and weight and body condition log. You can either download the kit here: www.pfma.org.uk/weighinwednesday or visit PFMA's homepage and ask for a free pack to be sent to your practice.
The BVA has paid tribute to Lord Ballyedmond, founder of the veterinary pharmaceutical company Norbrook Laboratories, after he was killed in a helicopter crash in Norfolk last Thursday.
The life peer (pictured second from left collecting a business award in 2011) founded Norbrook over 40 years ago. It became one of the biggest manufacturers of animal health products globally, and now employs more than 1000 people. Dr. Edward Haughey, as he was previously known, was ennobled in 2004.
Following his death, Norbrook issued the following statement:
"It is with sincere sadness and deep regret that the Company confirms our founding Chairman and CEO, Lord Ballyedmond, was one of four people who tragically lost their lives in an aviation accident at Gillingham, Norfolk at approximately 7.30pm on Thursday 13 March 2014.
Norbrook management and staff also mourn the loss of their friends and colleagues Declan Small (Site Foreman), Captain Carl Dickerson (Pilot) and Captain Lee Hoyle (Pilot).
Our thoughts are with the immediate families and friends of the deceased who have requested privacy at this difficult time.
We take enormous pride in our Chairman's extraordinary legacy in establishing Norbrook as a global veterinary and pharmaceutical industry leader. Management will continue to advance his pioneering vision with a renewed vigor and determination befitting his memory."
BVA President Robin Hargreaves said: "We are deeply saddened to hear of the tragic passing of Lord Ballyedmond. He has been a great supporter of the veterinary profession and of BVA, and made an enormous contribution to veterinary medicine. He built opportunity for thousands of people in Northern Ireland and around the world and had a huge commercial and industrial presence throughout my whole career. Above all Lord Ballyedmond was a family man and all our thoughts are with his wife and children at this time."
Merial has announced the launch of V LINE, a new range of parasiticides sold exclusively through veterinary practices.
The first two products, called Broadline for cats and NexGard for dogs, will be unveiled at the BSAVA Congress at the start of next month.
Broadline is a broad-acting POM spot-on for cats containing eprinomectin, praziquantel, s-methoprene and fipronil, indicated for use against tapeworms, ticks, roundworms and fleas.
NexGard is a POM flea and tick control product for dogs given monthly as a palatable soft chew. It contains a novel active ingredient called afoxolaner which, according to Merial, has a new and distinct mode of action that provides a fast speed of flea kill.
Roddy Webster, Head of Pets at Merial said: "We are pleased to announce the launch of Broadline and NexGard. Merial is a market leader with a strong heritage in anti-parasitics and we have leveraged that expertise as well as our understanding of what pet owners want, to deliver these truly consumer-focused solutions. Such prescription-only innovations also demonstrate our ongoing commitment to the veterinary profession."
Elanco Animal Health has announced that there have been extensions to the withdrawal periods for Dectomax (doramectin) 10 mg/ml Solution for Injection and Micotil (tilmicosin) 300 mg/ml Solution for Injection.
For Dectomax injectable, meat withdrawal for cattle and sheep will be extended to 70 days and pigs to 77 days. For Micotil, sheep milk withdrawal will be extended to 18 days and milk from cows during the dry period or from pregnant heifers should not be used for human consumption until 36 days after calving.
Elanco is reminding veterinary surgeons and SQPs that they may continue to prescribe according to the current label but it is good practice to implement revised withdrawal periods. The company is also taking this opportunity to highlight the importance of getting into the habit of double-checking withdrawal periods when administering drugs, because they do change from time to time in the light of new knowledge.
Axiom Veterinary Laboratories is launching MiLab, a new range of in-practice analysers at the BSAVA Congress.
Axiom says the range will be supported with a comprehensive range of additional services, from installation and training through to technical support and maintenance.
Martyn Carpenter, Managing Director of Axiom Veterinary Laboratories said: "An increasing number of UK veterinary practices are opting to carry out a higher proportion of laboratory testing in-house but, in order to do this successfully, they need equipment which is reliable, cost-effective and easy-to-use. Two products in the MiLab range will be showcased at BSAVA, both of which have been selected following extensive validation and correlation testing in Axiom's veterinary laboratories."
The two new products are:
Martyn said: "Investing in significant new equipment is always challenging for practices and we have spoken to many over the last 18 months to understand their experience of and current requirements for in-house analysis and, in particular, the level of support they receive. Practices working with us can be confident that we are offering the very latest in analyser technology, which has been tested rigorously for reliability, economy and ease of use. They can also feel secure in the knowledge that we provide a high level of service and support, delivered by our own highly skilled laboratory technicians."
For more information, contact Steve Clarke at Axiom on 01626 357756.
The RCVS Disciplinary Committee has restored Joseph Lennox Holmes to the Register of Veterinary Surgeons, two years after he was originally struck off.
Mr Holmes was removed from the Register in February 2012 after the Disciplinary Committee found him guilty of multiple charges of serious professional conduct. Mr Holmes lodged an appeal against the decision, which was heard and dismissed by the Privy Council.
The original charges related to two separate complaints; the first involved numerous charges in respect of Mr Holmes' treatment of a King Charles Spaniel between October 2007 and March 2008; the second, several charges in relation to his treatment of three cats in 2008.
The Committee found that the majority of the charges amounted to serious professional misconduct. In removing Mr Holmes from the Register, the Committee found that "aggravating factors in both... cases included actual injuries to the animals... and a serious breach of the trust which Mr Holmes' clients had placed in him to make the welfare of the animals his primary consideration according to the standards to be expected of the profession". In addition, the Committee cited 10 further aggravating factors including lack of reference to continuing professional development (CPD) in clinical policies and practices; lack of reference to accepted practice; lack of appreciation of the importance of adequate pain relief when performing painful surgical procedures; reluctance to consider referral as an option; and lack of understanding about what information is required by a client to enable fully informed consent to be given.
Following the dismissal of Mr Holmes' appeal by the Privy Council, his first application for restoration was heard by the Disciplinary Committee in February 2013. The Committee was not satisfied that he was fit to be restored to the Register, citing the fact that his application was "premature" and that he had failed to truly appreciate the seriousness of the findings against him. The Committee was also unimpressed with the efforts he had made to keep up-to-date with skills and developments in practice and with his CPD, noting in particular that he had made very limited attempts to observe the function and experience the culture of a modern first opinion practice.
However, in this week's two-day hearing, the Committee was satisfied that Mr Holmes was now fit to be restored to the Register. It heard that Mr Holmes had made a concerted effort to engage in CPD and bring his skills and knowledge up-to-date. During a period of observation at a veterinary practice, he had gained insight into modern practice and the need for veterinary general practitioners to be aware of the advantages in referring patients to specialists.
Professor Noreen Burrows, who chaired and spoke on behalf of the Disciplinary Committee, said: "The Committee has concluded that, in the course of genuine efforts to do what was necessary to address the deficiencies identified during the original Inquiry and at the last restoration hearing, the Applicant has at last understood the seriousness of his previous misconduct and has learned new skills and, most importantly, to recognise his limitations from the extensive course of study, reflection, and other training that he has undertaken."
Furthermore, the Committee was satisfied that Mr Holmes had gained a proper understanding of the importance of securing the informed consent of his clients and building a relationship of trust with them and, in addition, recognising the importance of maintaining close relations with fellow professionals and engaging with CPD opportunities.
Additional factors considered when making the decision included: that he had been off the Register for two years; that, through self-improvement, he had equipped himself to treat animals appropriately; the impact that being removed from the Register had in both personal and financial terms; his conduct since being removed from the Register; and, a number of positive testimonials from previous clients and professional colleagues.
The Committee's full findings and decision are available on the RCVS website (www.rcvs.org.uk/disciplinary).
Mike Brampton, inventor of the CAT Doppler blood pressure system and Managing Director of Thames Medical, is to start the 'Tour de Vet', a 1,300 mile tour of the UK during which he'll be stopping to give BP CPD and coaching to veterinary surgeons and nurses in return for a donation to the charity Canine Partners.
Mike says the CAT Doppler system is the most widely used in the UK. He also lectures at Nottingham Vet School and normally charges something in the order of £600 for talks and training sessions.
During the 'Tour de Vet', however, he'll be giving his talks free, in exchange for a donation to the charity of £250-£300.
Mike said: "At a recent BVNA Congress, 85% of nurses said they would like more skills and information in BP techniques. This is your chance to book some quality, certified, hands-on CPD at a massively reduced price, which will benefit not only your staff and practice but also help train a puppy for Canine Partners".
Mike's target is to raise £10,000.
The tour starts in Worthing on May 19th 2014. It ends three weeks and 1300 miles later at the Vettrust Conference in Stirling.
To book your blood pressure monitoring CPD or nurses' coaching, call Mike on 01903 522911 or email mike@thamesmedical.com.
Alternatively, if you just want to support his efforts, text 70070 with the code TDEV55 and your donation or visit http://www.justgiving.com/Tour-De-Vet
White Cross Vets, a group with 11 surgeries in the Midlands and the North of England, has picked up two Veterinary Marketing Association awards at an event usually dominated entirely by big pharma.
The group was joint winner of Public Relations Award, alongside Bayer Animal Health.
White Cross Marketing Manager Justin Phillips also walked off with the Young Marketeer of the Year award, fighting off competition from Elizabeth Rawlings from Dechra and Beverly Hammond from Animalcare Ltd.
The practice group won the PR Award for a campaign in which it managed to generate a massive amount of media coverage for the business primarily by spotting a good opportunity, and acting quickly to make the most of it.
The story began last July, when a man spotted an exotic-looking bird walking around Guisely, near Leeds. When he tried to capture the bird, it told him to 'bugger off'. Undeterred, he picked it up and took it to White Cross Vets. Once the vets had examined the bird to make sure it was in good health, White Cross instructed its PR agency to begin a media campaign to reunite the animal with its owner. The resultant story generated over £145,000 worth of branded coverage in local and national media, including the Daily Mirror, Metro, the Yorkshire Post and ITV.
By contrast, Bayer Animal Health's winning campaign, which ingeniously used LED lights strapped to snails to bring the lungworm story to life, was nevertheless the product of month's of planning and what would have been a considerable budget.
The judges felt both entries were impressive in completely different ways, so a draw was the only option.
Picture shows, left to right: Heidi Bruckland (Pegasus), Emma Swain (Pegasus), Helen Moore (Markettiers4DC), Marcus Edingloh (Bayer), Luke Hopkins (Pegasus), Caroline Braidwood (Bayer); Jane Manning (Splash); Tim Harrison (White Cross Vets); Justin Phillips (White Cross Vets)
Vétoquinol has announced the return of Navilox powder (isoxsuprine hydrochloride), the only medication specifically licensed in the UK for use in cases of navicular disease in horses.
Navicular disease is a chronic degenerative condition of the navicular bone and associated structures. It is a syndrome with a complex pathogenesis which combines various underlying causes. Vétoquinol says it is a common cause of lameness in the middle aged riding horse.
Robert Simpson, Navilox Product Manager said: "Navilox has been sorely missed by equine vets in the UK which is why I am thrilled to be able to announce that it is available again."
To order Navilox powder, call Vétoquinol on 01280 825424 or contact your wholesaler directly.